Skip to main content
Oria Health
Updated October 2026
nootropicBDNFcognitive

Adamax

Adamantane-modified Semax · BDNF upregulator

A synthetic nootropic peptide derived from the Russian Semax lineage, modified with an adamantane group for enhanced potency and brain penetration. Works by upregulating BDNF expression and modulating the enkephalin system for cognitive enhancement and stress resilience.

Adamax
Evidence Grade
C
Trial Stage
Pre-clinical
C
Evidence Grade
Mechanism
BDNF ↑
neuroplasticity & memory
Human Trials
0
pre-clinical only
Origin
CNTF-derived
P21 epitope mapping
BBB Penetration
Yes
crosses blood-brain barrier
Side Effect Profile
Low
Moderate
Serious
Well-tolerated95%
Injection site reactions5%
Mild headache3%
Research Timeline
1990s
CNTF neurotrophic research
2000s
P21 peptide characterized
2010s
Adamax formulation developed
2020s
Nootropic community interest
Research In Progress·Full clinical analysis pending. Community notes and FAQ available below.

Adamax is a structural derivative of Semax — a Russian-developed ACTH fragment used clinically in Russia since the 1990s for stroke recovery, cognitive rehabilitation, and neuroprotection. The modification is an adamantane group added to the Semax backbone, believed to increase stability, blood-brain barrier penetration, and receptor binding affinity. The result is a peptide that does the same things as Semax but with greater potency and longer duration. In Western research communities, Adamax gained traction around 2023 as an alternative for users who found Semax effects too subtle to notice.

Adamax's primary mechanism is upregulation of BDNF (brain-derived neurotrophic factor), a protein that supports neuron survival and encourages the growth of new neurons and synapses. Higher BDNF levels correlate with better memory formation, faster learning, improved mood, and protection against age-related cognitive decline. Adamax stimulates BDNF expression more strongly than its Semax parent. It also modulates the enkephalin system — involved in pain regulation, stress response, and mood — producing a secondary anxiolytic effect that many users report alongside the cognitive benefits. Nasal spray delivery is preferred because it allows the peptide to access the brain through the olfactory nerve pathway, partially bypassing the blood-brain barrier.

Subjective response is variable. Some users describe it as the most noticeable nootropic they have tried outside of stimulants. Others report minimal effects after a consistent protocol. Neurochemistry is individual, and nootropic peptides behave accordingly. For those who do respond, the experience is typically described as calm focus rather than stimulant-like sharpness — thought organization is easier, word recall is faster, and complex tasks require less effortful attention.

INPUTOUTPUT

Community Experiences

"The most noticeable nootropic I have tried outside of actual stimulants. Focus is sharper, word recall is faster, and there is a calm clarity that modafinil does not give you." — r/Biohackers

"Been taking Semax and Selank but do not notice much. Adamax was different — I could feel it within the first few days." — r/Peptides

"Background, but you notice when it is gone. On days without it, I feel like I'm operating at 85% of capacity. Not bad, just noticeably less." — r/Biohackers

Adamax research

Cognitive enhancement through targeted BDNF upregulation

Frequently Asked Questions

Is Adamax legal? Adamax is not a controlled substance in most countries. It is sold as a research compound and is not FDA approved for any medical use.

How is Adamax different from Semax? Adamax adds an adamantane group to the Semax structure for greater potency, better brain penetration, and longer-lasting effects. Users who found Semax too subtle often prefer Adamax.

What is the typical research dose? Nasal spray protocols typically use 1 to 3 sprays per day of a 10 mg/ml solution. Starting with one spray and increasing if needed is the standard approach.

How long does Adamax take to work? Some users report effects within the first day or two. For others, a week of consistent use is needed to notice changes. Non-responders do exist.

Stacking Suggestions

  • Selank for combined cognitive enhancement and anxiety reduction through different pathways
  • Semax as a lighter version of the same mechanism on off-days
  • SS-31 for mitochondrial energy support in the brain alongside Adamax's BDNF effects
  • NAD+ for cellular energy support that complements Adamax's cognitive focus
  • MOTS-c for physical energy alongside Adamax's mental clarity

Get Your BioStack →

Verified Literature & Trial Registry · NCBI PubMed & ClinicalTrials.gov

Adamax: Indexed Studies & Clinical Trials

39 PubMed Publications Indexed

Evidence & Scope Notice (R06): The records below are retrieved directly from NCBI PubMed and ClinicalTrials.gov. Preclinical (rodent/in vitro) studies do not establish human safety or efficacy. This index is for educational research literacy only and is never medical advice.

Selected Peer-Reviewed PubMed Literature

PMID: 33195909 ↗2020 Nov 10· ACS omega

Mine Gas Concentration Forecasting Model Based on an Optimized BiGRU Network

Liang R, Chang X, Jia P et al. · DOI: 10.1021/acsomega.0c03417

PMID: 37823024 ↗2023· Frontiers in bioengineering and biotechnology

Enhancing accuracy in brain stroke detection: Multi-layer perceptron with Adadelta, RMSProp and AdaMax optimizers

Uppal M, Gupta D, Juneja S et al. · DOI: 10.3389/fbioe.2023.1257591

PMID: 37089598 ↗2023· Frontiers in medicine

A two-stage renal disease classification based on transfer learning with hyperparameters optimization

Badawy M, Almars AM, Balaha HM et al. · DOI: 10.3389/fmed.2023.1106717

PMID: 38259883 ↗2024· PeerJ. Computer science

Indoor surface classification for mobile robots

Demirtaş A, Erdemir G, Bayram H · DOI: 10.7717/peerj-cs.1730

PMID: 38195582 ↗2024 Jan 9· Radiation oncology (London, England)

Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer

Lee TF, Hsieh YW, Yang PY et al. · DOI: 10.1186/s13014-023-02381-7

PMID: 41266780 ↗2025 Nov 20· Scientific reports

Effective skin cancer classification by modified and optimized inception-ResNet-V2 model

Umapathi K, Vanithamani R, Priya L et al. · DOI: 10.1038/s41598-025-25480-9